Polymodal Reconnaissance in Urothelial Cancer Deploying Epigenetic Network and Transcriptome Analyses

Polymodal Reconnaissance in Urothelial Cancer Deploying Epigenetic Network and Transcriptome Analyses - PRUDENT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00013039

Enrollment

200

Registered

2018-03-15

Start date

2018-03-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C67 C66 C65

Interventions

Group 1: Analysis of tissue/blood/urine after completion of routine diagnostics.

Eligibility

Sex/Gender

All

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: Indication to transurethral or open resection of urothelial cancer. Consent provided.

Exclusion criteria

Exclusion criteria: Consent not provided. Consent cannot be given by the patient themselve.

Design outcomes

Primary

Measure	Time frame
Molecular and histological characterization.	—

Secondary

Measure	Time frame
Correlation to clinical data. Prediction regarding response to therapy, progress, recurrence.	—

Countries

Germany

Contacts

Public ContactSimon Hein

Universitätsklinikum FreiburgDepartment ChirurgieKlilnik für Urologie

simon.hein@uniklinik-freiburg.de0761/270-25820 und 28930

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026